256 related articles for article (PubMed ID: 20956181)
1. Mucoactive drugs.
Balsamo R; Lanata L; Egan CG
Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
[TBL] [Abstract][Full Text] [Related]
2. Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians.
Yan X; Song Y; Shen C; Xu W; Chen L; Zhang J; Liu H; Huang M; Lai G; Qian G; Wang J; Ye X; Zheng J; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():803-812. PubMed ID: 28405161
[TBL] [Abstract][Full Text] [Related]
3. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).
Shen Y; Huang S; Kang J; Lin J; Lai K; Sun Y; Xiao W; Yang L; Yao W; Cai S; Huang K; Wen F
Int J Chron Obstruct Pulmon Dis; 2018; 13():399-407. PubMed ID: 29430174
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review).
Zhang T; Zhou X
Exp Ther Med; 2014 Apr; 7(4):763-767. PubMed ID: 24660026
[TBL] [Abstract][Full Text] [Related]
5. The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
Hooper C; Calvert J
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):659-69. PubMed ID: 19281081
[TBL] [Abstract][Full Text] [Related]
6. Clinical issues of mucus accumulation in COPD.
Ramos FL; Krahnke JS; Kim V
Int J Chron Obstruct Pulmon Dis; 2014; 9():139-50. PubMed ID: 24493923
[TBL] [Abstract][Full Text] [Related]
7. Rational use of mucoactive medications to treat pediatric airway disease.
Linssen RSN; Ma J; Bem RA; Rubin BK
Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary disease.
Tian PW; Wen FQ
J Transl Int Med; 2015; 3(3):89-92. PubMed ID: 27847895
[TBL] [Abstract][Full Text] [Related]
9. A reappraisal of the mucoactive activity and clinical efficacy of bromhexine.
Zanasi A; Mazzolini M; Kantar A
Multidiscip Respir Med; 2017; 12():7. PubMed ID: 28331610
[TBL] [Abstract][Full Text] [Related]
10. Reply letter to Adeli and Jazi - "Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion".
Tang W; Zhu D; Wu F; Xu JF; Yang JP; Deng ZP; Chen XB; Papi A; Qu JM
Eur Rev Med Pharmacol Sci; 2024 May; 28(10):3477-3478. PubMed ID: 38856122
[No Abstract] [Full Text] [Related]
11. Letter to the Editor on: Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion.
Adeli SH; Jazi K
Eur Rev Med Pharmacol Sci; 2024 Apr; 28(8):2986-2987. PubMed ID: 38708454
[No Abstract] [Full Text] [Related]
12. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Black PN; Cates CJ
Cochrane Database Syst Rev; 2012 Aug; (8):CD001287. PubMed ID: 22895919
[TBL] [Abstract][Full Text] [Related]
13. Over-the-counter (OTC) medications for acute cough in children and adults in community settings.
Smith SM; Schroeder K; Fahey T
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD001831. PubMed ID: 25420096
[TBL] [Abstract][Full Text] [Related]
14. Mucoactive therapy in COPD.
Decramer M; Janssens W
Eur Respir Rev; 2010 Jun; 19(116):134-40. PubMed ID: 20956182
[TBL] [Abstract][Full Text] [Related]
15. Role of mucolytics in wet cough.
Dhar R
J Assoc Physicians India; 2013 May; 61(5 Suppl):23-7. PubMed ID: 24490447
[No Abstract] [Full Text] [Related]
16. Secretion properties, clearance, and therapy in airway disease.
Rubin BK
Transl Respir Med; 2014; 2():6. PubMed ID: 25505698
[TBL] [Abstract][Full Text] [Related]
17. Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells.
Seagrave J; Albrecht HH; Hill DB; Rogers DF; Solomon G
Respir Res; 2012 Oct; 13(1):98. PubMed ID: 23113953
[TBL] [Abstract][Full Text] [Related]
18. The role of mucoregulatory agents after continence-preserving urinary diversion surgery.
Covert WM; Westin SN; Soliman PT; Langley GD
Am J Health Syst Pharm; 2012 Mar; 69(6):483-6. PubMed ID: 22382478
[TBL] [Abstract][Full Text] [Related]
19. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
